Stem+Cell+Ophthalmology+Treatment+Study+(SCOTS)+for+retinal+and+optic+nerve+diseases：a+case+report+of+improvement+in+relapsing+auto-immune+optic+neuropathy.pdfVIP

NEURAL REGENERATION RESEARCH September 2015,Volume 10,Issue 9 RESEARCH ARTICLE Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy 1 2, * 3 Jeffrey N. Weiss , Steven Levy , Susan C. Benes 1 Retina Associates of South Florida, Margate, FL, USA 2 MD Stem Cells, Ridgefield, CT, USA 3 Wilmer Eye Institute, The Johns Hopkins Hospital, Baltimore, MD, USA Abstract *Correspondence to: We present the results from a patient with relapsing optic neuropathy treated within the Stem Steven Levy, M.D., Cell Ophthalmology Treatment Study (SCOTS). SCOTS is an Institutional Review Board ap- stevenlevy@. proved clinical trial and has become the largest ophthalmology stem cell study registered at the National Institutes of Health to date ( Identifier NCT. SCOTS orcid: utilizes autologous bone marrow-derived stem cells (BMSCs) for treatment of retinal and optic 0000-0002-9313-3448 (Steven Levy) nerve diseases. Pre-treatment and post-treatment comprehensive eye exams of a 54 year old female patient were performed both at the Florida Study Center, USA and at The Eye Center of doi: 10.4103/1673-5374.165525 Columbus, USA. As a consequence of a relapsing optic neuritis, the patient’s previously normal / visual acuity decreased to between 20/350 and 20/400 in the right eye and to 20/70 in the left eye.